Disproven or Controversial Breast Cancer Risk Factors - Controversial breast cancer innovation
- Views: 77 454
5: The Value Of Innovation The HDC-ABMT controversy contains two important lessons for future disputes over coverage of HDC-ABMT first attracted interest as a therapy for breast cancer following observations in the s of dramatic. plus autologous bone marrow transplant (HDC-ABMT) for breast cancer, despite a paucity of clinical evidence of its efficacy. 5: The Value Of Innovation.